CLINICAL-STUDY OF THE ASSOCIATION OF VERAPAMIL AND CAPTOPRIL IN HYPERTENSIVE PATIENTS NOT CONTROLLED WITH MONOTHERAPY - EVALUATION BY THE 24-HOUR AMBULATORY BLOOD-PRESSURE MONITORING
J. Moramacia et al., CLINICAL-STUDY OF THE ASSOCIATION OF VERAPAMIL AND CAPTOPRIL IN HYPERTENSIVE PATIENTS NOT CONTROLLED WITH MONOTHERAPY - EVALUATION BY THE 24-HOUR AMBULATORY BLOOD-PRESSURE MONITORING, Medicina Clinica, 100(14), 1993, pp. 526-530
BACKGROUND: By measuring ambulatory blood pressure monitoring (ABPM),
the pharmacologic association of verapamil plus captopril in essential
hypertensive patients not responding to isolated monotherapy of these
drugs was studied since a synergism has been described between these
two drugs. METHODS: A lineal clinical trial with a previous period of
selection (PeSe) in which verapamil and captopris were administered in
two consecutive phases was carried out in 57 essential hypertensive p
atients of 52 +/- 19 years of age with those controlling their blood p
ressure (BP) being excluded. Following a lavage phase the remaining su
bjects were included in the experimental period (ExPe) in wash out the
association of verapamil 120 mg + captopril 25 mg was administered an
d if the BP was not controlled this was increased to 240 mg + 50 mg, r
espectively. ABPM was performed prior to and at the end of the ExPe. R
ESULTS: Of the 57 patients 21 were excluded in the SePe due to control
or adverse effects. Of the 26 individuals who passed into the ExPe 20
presented mild-moderate HTA (M-HTA) and 6 severe HTA (S-HTA). In the
M-HTA group, the reduction of BP (in mmHg) was 157 +/- 15/106 +/- 5 to
147 +/- 12/97 +/- 7 (p < 0.05/p < 0.001), five controlled BP, in the
remaining subjects the reduction in the following phase was 150 +/- 11
/100 +/- 6 at 136 +/- 11/93 +/- 6 (p < 0.01/p < 0.01). In the S-HTA gr
oup the BP descended in the ExPe from 184 +/- 15/121 +/- 6 to 167 +/-2
4/107 +/- 10 (p < 0.05/p < 0.05). The 24 hour measurement of BP in the
ExPe decreased from 140 +/- 13/96 +/- 8 to 124 +/- 10/86 +/- 7 (p < 0
.001/p < 0.001). BP descended significantly in all the hours with the
exception of the hours 24, 1, 6, 7, and 5. CONCLUSIONS: The associatio
n of verapamil-captopril demonstrates efficacy and synergism in hypert
ensive patients previously uncontrolled by monotherapy of these drugs.